Aarvik Therapeutics
About
Reengineering life-saving injections. Top fundraiser on Wefunder raising $452,803 in a single week (ending Feb 21, 2026) with $3.05M total raised. Working to improve the delivery and effectiveness of critical injectable medications.
AI Investment Summary
Top Wefunder campaign with $3M+ raised and $452K raised in a single week. Reengineering life-saving injections. Strong community interest and momentum.
Structure
Direct Equity
Stage
Seed
Accreditation
Open to All
Liquidity
Illiquid
Geography
United States
Revenue
pre revenue
Total Investors
2,000
Green Flags
- $3M+ total raised — top Wefunder campaign
- $452K raised in single week
- Life-saving medical innovation
- Strong investor momentum
Risk Flags
- Pre-revenue biotech
- FDA regulatory pathway
- Drug delivery market is competitive
- Capital-intensive development
Similar Deals in Biotech & Pharma
Rexis Biotech
Seed
Biotech ingredients improving supplement absorption — $14.7M projected revenue.
Min. Investment
$100
Funded
45%
Oxeia Biopharma
Series A
First potential FDA-approved concussion treatment — Phase 2b clinical.
Min. Investment
$500
Funded
55%
Minimum Investment
$100
Lock-up Period
5 years (until exit)
Tags
LISTED
2025-11-01